United States · FDA National Drug Code directory
Warfarin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-574_1997af85-ab19-433b-9467-e360932e3edf
- Product NDC
- 71610-574
- Form
- TABLET
- Composition / generic term
- Warfarin Sodium
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19990715
- Source listing expiry
- 20261231
Source-listed ingredients
- WARFARIN SODIUM — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71610-574-30) · 71610-574-30
- 35 TABLET in 1 BOTTLE (71610-574-35) · 71610-574-35
- 40 TABLET in 1 BOTTLE (71610-574-40) · 71610-574-40
- 45 TABLET in 1 BOTTLE (71610-574-45) · 71610-574-45
- 60 TABLET in 1 BOTTLE (71610-574-53) · 71610-574-53
- 90 TABLET in 1 BOTTLE (71610-574-60) · 71610-574-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →